Evaluation of the Efficacy and Safety of Molnupiravir Treatment in Mild/Moderate Covid-19 Patients.
Clinical trial NCT06223932 · UNKNOWN
Trial details
- NCT number
- NCT06223932
- Sponsor
- Serap Yavuz
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2022-07-07
- Primary completion
- 2024-02-01
- Enrollment
- 2600
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.